SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019797
Filing Date
2024-07-18
Accepted
2024-07-18 20:05:14
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 form3-07192024_120709.html 3  
1 form3-07192024_120709.xml 3 10516
  Complete submission text file 0001415889-24-019797.txt   12920
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 107 IHYEON-RO,30BEON-GIL GILHEUNG-GU, YONGIN-SI GYEONGGI-DO M5 16924
Business Address 107 IHYEON-RO,30BEON-GIL GILHEUNG-GU, YONGIN-SI GYEONGGI-DO M5 16924 82-31-260-9300
GC Corp. (Reporting) CIK: 0001931382 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42179 | Film No.: 241125805

Mailing Address 107 IHYEON-RO, 30BEON-GIL GILHEUNG-GU, YONGIN-SI GYEONGGI-DO M5 16924
Business Address 107 IHYEON-RO, 30BEON-GIL GILHEUNG-GU, YONGIN-SI GYEONGGI-DO M5 16924 82-31-260-9300
GC Cell Corp (Reporting) CIK: 0001931891 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42179 | Film No.: 241125804